True Wealth Design’s Pulse Biosciences PLSE Stock Holding History

True Wealth Design’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2	Closed	-$31	–	2843
2025 Q2	$31	Hold	2	–	–	﹤0.01%	2467
2025 Q1	$33	Buy	+2	New	+$37	﹤0.01%	2485

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

True Wealth Design's PLSE Position: Q3 2025 in Review

True Wealth Design sold out of Pulse Biosciences (PLSE) in Q3 2025, closing a stake of 2 shares — an estimated $31 sold.

True Wealth Design first reported a position in PLSE in Q1 2025 and held it in 2 quarters. The position peaked at $33 in Q1 2025. 84 funds tracked by Wall St. Rank hold PLSE as of Q3 2025.

True Wealth Design reported no remaining Pulse Biosciences position as of Q3 2025 after selling out during the quarter.
True Wealth Design sold 2 Pulse Biosciences shares in Q3 2025, an estimated $31.
True Wealth Design first reported a position in Pulse Biosciences in Q1 2025 and held it in 2 quarters.
True Wealth Design's Pulse Biosciences position peaked at $33 in Q1 2025.
84 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2025.

Based on True Wealth Design's 13F filing for Q3 2025, filed 21 Oct 2025.